This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Bruce M. Psaty, MD, PhD; Susan R. Heckbert, MD, PhD; Thomas D. Koepsell, MD, MPH; David S. Siscovick, MD, MPH; Trivellore E. Raghunathan, PhD; Noel S. Weiss, MD, DrPH; Frits R. Rosendaal, MD; Rozenn N. Lemaitre, PhD, MPH; Nicholas L. Smith, MPH; Patricia W. Wahl, PhD; Edward H. Wagner, MD, MPH; Curt D. Furberg, MD, PhD

JAMA. 1995;274(8):620-625.

Abstract
Objective.
—To assess the association between first myocardial infarction and the use of antihypertensive agents.

Design and Setting.
—We conducted a population-based case-control study among enrollees of the Group Health Cooperative of Puget Sound (GHC).

Patients and Methods.
—Cases were hypertensive patients who sustained a first fatal or nonfatal myocardial infarction from 1986 through 1993 among women and from 1989 through 1993 among men. Controls were a stratified random sample of hypertensive GHC enrollees, frequency matched to the cases on age, sex, and calendar year. All 623 cases and 2032 controls had pharmacologically treated hypertension. Data collection included a review of the ambulatory medical record and a brief telephone interview of consenting survivors. Antihypertensive therapy was assessed using the GHC's computerized pharmacy database.

Results.
—The first analysis included only the 335 cases and 1395 controls initially free of cardiovascular disease. Compared with users of diuretics alone, the adjusted risk ratio of myocardial infarction was increased by about 60% among users of calcium channel blockers with or without diuretics (risk ratio=1.62; 95% confidence interval [CI], 1.11 to 2.34; P=.01). The second analysis was restricted to 384 cases and 1108 controls who were taking either a calcium channel blocker or a β-blocker. Among these subjects, the use of calcium channel blockers compared with β-blockers was associated with about a 60% increase in the adjusted risk of myocardial infarction (risk ratio=1.57; 95% CI, 1.21 to 2.04; P<.001). While high doses of β-blockers were associated with a decreased risk of myocardial infarction (trend P=.04), high doses of calcium channel blockers were associated with an increased risk (trend P<.01).

Conclusions.
—In this study of hypertensive patients, the use of short-acting calcium channel blockers, especially in high doses, was associated with an increased risk of myocardial infarction. Ongoing large-scale clinical trials will assess the effect of various antihypertensive therapies, including calcium channel blockers, on several important cardiovascular end points. Until these results are available, the findings of this study support the current guidelines from the Joint National Committee on the Detection, Evaluation and Treatment of High Blood Pressure that recommend diuretics and β-blockers as first-line agents unless contraindicated, unacceptable, or not tolerated.

(JAMA. 1995;274:620-625)

Author Affiliations
From the Cardiovascular Health Research Unit, the Departments of Medicine (Drs Psaty, Koepsell, and Siscovick), Epidemiology (Drs Psaty, Heckbert, Koepsell, Siscovick, Weiss, Lemaitre, and Smith), Biostatistics (Dr Wahl), and Health Services (Drs Psaty, Koepsell, and Wagner), University of Washington, Seattle; Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor (Dr Raghunathan); Department of Clinical Epidemiology, University Hospital, Leiden, the Netherlands (Dr Rosendaal); the Center for Health Studies, Group Health Cooperative of Puget Sound, Seattle, Wash (Dr Wagner); and Department of Public Health Sciences, Bowman Gray School of Medicine, Winston-Salem, NC (Dr Furberg).

Footnotes
Reprints requests to Cardiovascular Health Research Unit, Metropolitan Park, East Tower, Suite 1360, 1730 Minor Ave, Seattle, WA 98101 (Dr Psaty).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Hypertension, Heart Failure, and Beta-Adrenergic Blocking Drugs
Fowler
J Am Coll Cardiol 2008;52:1073-1075.
FULL TEXT  

Use of Alendronate and Risk of Incident Atrial Fibrillation in Women
Heckbert et al.
Arch Intern Med 2008;168:826-831.
ABSTRACT | FULL TEXT  

Management of Cocaine-Associated Chest Pain and Myocardial Infarction: A Scientific Statement From the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology
McCord et al.
Circulation 2008;117:1897-1907.
FULL TEXT  

Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology
Authors/Task Force Members et al.
Eur Heart J 2007;28:1598-1660.
FULL TEXT  

Renin-Angiotensin System Haplotypes and the Risk of Myocardial Infarction and Stroke in Pharmacologically Treated Hypertensive Patients
Marciante et al.
Am J Epidemiol 2007;166:19-27.
ABSTRACT | FULL TEXT  

Association of Genetic Variations With Nonfatal Venous Thrombosis in Postmenopausal Women
Smith et al.
JAMA 2007;297:489-498.
ABSTRACT | FULL TEXT  

Conjugated Equine Estrogen, Esterified Estrogen, Prothrombotic Variants, and the Risk of Venous Thrombosis in Postmenopausal Women
Smith et al.
Arterioscler. Thromb. Vasc. Bio. 2006;26:2807-2812.
ABSTRACT | FULL TEXT  

Risk of New-Onset Atrial Fibrillation in Relation to Body Mass Index
Dublin et al.
Arch Intern Med 2006;166:2322-2328.
ABSTRACT | FULL TEXT  

Pathobiological Determinants of Atherosclerosis in Youth Risk Scores Are Associated With Early and Advanced Atherosclerosis
McMahan et al.
Pediatrics 2006;118:1447-1455.
ABSTRACT | FULL TEXT  

Pharmacologic management of stable angina: role of ivabradine
Steg and Tchetche
Eur Heart J Suppl 2006;8:D16-D23.
ABSTRACT | FULL TEXT  

Statin and beta-blocker therapy and the initial presentation of coronary heart disease.
Go et al.
ANN INTERN MED 2006;144:229-238.
ABSTRACT | FULL TEXT  

Different effects of long- and short-acting loop diuretics on survival rate in Dahl high-salt heart failure model rats
Yoshida et al.
Cardiovasc Res 2005;68:118-127.
ABSTRACT | FULL TEXT  

Calcium Antagonists: Effects on Cardio-Renal Risk in Hypertensive Patients
Nathan et al.
Hypertension 2005;46:637-642.
ABSTRACT | FULL TEXT  

Unmet medical needs and therapeutic opportunities in stable angina
Gabriel Steg and Himbert
Eur Heart J Suppl 2005;7:H7-H15.
ABSTRACT | FULL TEXT  

Contemporary management of acute coronary syndrome
Large
Postgrad. Med. J. 2005;81:217-222.
ABSTRACT | FULL TEXT  

Benidipine, a long-acting calcium channel blocker, inhibits cardiac remodeling in pressure-overloaded mice
Liao et al.
Cardiovasc Res 2005;65:879-888.
ABSTRACT | FULL TEXT  

Translating Research into Practice: Are Physicians Following Evidence-Based Guidelines in the Treatment of Hypertension?
Holmes et al.
Med Care Res Rev 2004;61:453-473.
ABSTRACT  

Magnesium Inhibits Norepinephrine Release by Blocking N-Type Calcium Channels at Peripheral Sympathetic Nerve Endings
Shimosawa et al.
Hypertension 2004;44:897-902.
ABSTRACT | FULL TEXT  

Esterified Estrogens and Conjugated Equine Estrogens and the Risk of Venous Thrombosis
Smith et al.
JAMA 2004;292:1581-1587.
ABSTRACT | FULL TEXT  

Quantifying Risk of Adverse Clinical Events With One Set of Vital Signs Among Primary Care Patients with Hypertension
Tierney et al.
Ann Fam Med 2004;2:209-217.
ABSTRACT | FULL TEXT  

Relationship between Blood Glucose Control, Pathogenesis and Progression of Diabetic Nephropathy
Nosadini and Tonolo
J. Am. Soc. Nephrol. 2004;15:S1-5.
ABSTRACT | FULL TEXT  

Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease and Risk of Death and Hospitalization: Time-dependent Analysis
Fan et al.
Am. J. Respir. Crit. Care Med. 2003;168:1488-1494.
ABSTRACT | FULL TEXT  

A Calcium Antagonist vs a Non-Calcium Antagonist Hypertension Treatment Strategy for Patients With Coronary Artery Disease: The International Verapamil-Trandolapril Study (INVEST): A Randomized Controlled Trial
Pepine et al.
JAMA 2003;290:2805-2816.
ABSTRACT | FULL TEXT  

Genetic variants of coagulation factor XIII, postmenopausal estrogen therapy, and risk of nonfatal myocardial infarction
Reiner et al.
Blood 2003;102:25-30.
ABSTRACT | FULL TEXT  

ALLHAT: definitive answers or continuing uncertainty?
Sever
Journal of Renin-Angiotensin-Aldosterone System 2003;4:3-5.
 

Effect of preoperative {beta}-blockade on perioperative mortality in coronary surgery
ten Broecke et al.
Br J Anaesth 2003;90:27-31.
ABSTRACT | FULL TEXT  

The Verdict From ALLHAT--Thiazide Diuretics Are the Preferred Initial Therapy for Hypertension
Appel
JAMA 2002;288:3039-3042.
FULL TEXT  

Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Bertrand et al.
Eur Heart J 2002;23:1809-1840.
FULL TEXT  

Bruce Psaty and the risks of calcium channel blockers
Deyo
Qual Saf Health Care 2002;11:294-296.
FULL TEXT  

Chronic Renal Diseases: Renoprotective Benefits of Renin-Angiotensin System Inhibition
Remuzzi et al.
ANN INTERN MED 2002;136:604-615.
ABSTRACT | FULL TEXT  

Diuretic Therapy, the {alpha}-Adducin Gene Variant, and the Risk of Myocardial Infarction or Stroke in Persons With Treated Hypertension
Psaty et al.
JAMA 2002;287:1680-1689.
ABSTRACT | FULL TEXT  

First-line treatment for hypertension
Jackson and Ramsay
Eur Heart J 2002;23:179-182.
FULL TEXT  

Autonomic Tone as a Cardiovascular Risk Factor: The Dangers of Chronic Fight or Flight
Curtis and O'Keefe
Mayo Clin Proc. 2002;77:45-54.
ABSTRACT  

Guidelines for the Management of Patients with Chronic Stable Angina: Treatment
Fihn et al.
ANN INTERN MED 2001;135:616-632.
ABSTRACT | FULL TEXT  

Epidemiologic Review of the Calcium Channel Blocker Drugs: An Up-to-date Perspective on the Proposed Hazards
Kizer and Kimmel
Arch Intern Med 2001;161:1145-1158.
ABSTRACT | FULL TEXT  

Verapamil Metabolism in Distinct Regions of the Heart and in Cultures of Cardiomyocytes of Adult Rats
Walles et al.
Drug Metab. Dispos. 2001;29:761-768.
ABSTRACT | FULL TEXT  

Characterization of a Novel Cationic Drug Transporter in Human Retinal Pigment Epithelial Cells
Han et al.
J. Pharmacol. Exp. Ther. 2001;296:450-457.
ABSTRACT | FULL TEXT  

Intercurrent drug therapy and perioperative cardiovascular mortality in elective and urgent/emergency surgical patients{{dagger}}
Sear et al.
Br J Anaesth 2001;86:506-512.
ABSTRACT | FULL TEXT  

Hormone Replacement Therapy, Prothrombotic Mutations, and the Risk of Incident Nonfatal Myocardial Infarction in Postmenopausal Women
Psaty et al.
JAMA 2001;285:906-913.
ABSTRACT | FULL TEXT  

Left Ventricle and Arteries : Structure, Function, Hormones, and Disease
Cohn
Hypertension 2001;37:346-349.
ABSTRACT | FULL TEXT  

Antihypertensive Drug Therapies and the Risk of Ischemic Stroke
Klungel et al.
Arch Intern Med 2001;161:37-43.
ABSTRACT | FULL TEXT  

RR interval variation, the QT interval index and risk of primary cardiac arrest among patients without clinically recognized heart disease
Whitsel et al.
Eur Heart J 2001;22:165-173.
ABSTRACT  

Selection by Indication of Potent Antiretroviral Therapy Use in a Large Cohort of Women Infected with Human Immunodeficiency Virus
Ahdieh et al.
Am J Epidemiol 2000;152:923-933.
ABSTRACT | FULL TEXT  

Hypertension and Its Treatment in Postmenopausal Women : Baseline Data from the Women's Health Initiative
Wassertheil-Smoller et al.
Hypertension 2000;36:780-789.
ABSTRACT | FULL TEXT  

Randomised comparison of the effects of nicardipine and esmolol on coronary artery wall stress: implications for the risk of plaque rupture
Williams et al.
Heart 2000;84:377-382.
ABSTRACT | FULL TEXT  

National Guidelines, Clinical Trials, and Quality of Evidence
Psaty et al.
Arch Intern Med 2000;160:2577-2580.
FULL TEXT  

Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation. Recommendations of the Task Force of the European Society of Cardiology: Recommendations of the Task Force of the European Society of Cardiology
Bertrand et al.
Eur Heart J 2000;21:1406-1432.
 

Self-reported Hypertension Treatment Practices Among Primary Care Physicians: Blood Pressure Thresholds, Drug Choices, and the Role of Guidelines and Evidence-Based Medicine
Hyman and Pavlik
Arch Intern Med 2000;160:2281-2286.
ABSTRACT | FULL TEXT  

Use of Calcium Channel Blockers and Risk of Hospitalized Gastrointestinal Tract Bleeding
Kaplan et al.
Arch Intern Med 2000;160:1849-1855.
ABSTRACT | FULL TEXT  

The Risk of Myocardial Infarction Associated with Inhaled beta -Adrenoceptor Agonists
AU et al.
Am. J. Respir. Crit. Care Med. 2000;161:827-830.
ABSTRACT | FULL TEXT  

Control of Blood Pressure and Risk of Stroke Among Pharmacologically Treated Hypertensive Patients
Klungel et al.
Stroke 2000;31:420-424.
ABSTRACT | FULL TEXT  

Calcium-Antagonist Drugs
Abernethy and Schwartz
NEJM 1999;341:1447-1457.
FULL TEXT  

Randomized Double-Blind Comparison of a Calcium Antagonist and a Diuretic in Elderly Hypertensives
Hypertension 1999;34:1129-1133.
ABSTRACT | FULL TEXT  

Hypertension and diabetic retinopathy---what's the story?
GILLOW et al.
Br J Ophthalmol 1999;83:1083-1087.
FULL TEXT  

Are Surrogate Markers Adequate to Assess Cardiovascular Disease Drugs?
Temple
JAMA 1999;282:790-795.
FULL TEXT  

ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina)
Gibbons et al.
J Am Coll Cardiol 1999;33:2092-2197.
FULL TEXT  

Meta-analysis of Trials Comparing {beta}-Blockers, Calcium Antagonists, and Nitrates for Stable Angina
Heidenreich et al.
JAMA 1999;281:1927-1936.
ABSTRACT | FULL TEXT  

Predictors and Mediators of Successful Long-term Withdrawal From Antihypertensive Medications
Espeland et al.
Arch Fam Med 1999;8:228-236.
ABSTRACT | FULL TEXT  

Trends in Antihypertensive Drug Advertising, 1985–1996
Wang et al.
Circulation 1999;99:2055-2057.
ABSTRACT | FULL TEXT  

Meta-analysis and Epidemiologic Studies in Drug Development and Postmarketing Surveillance
Temple
JAMA 1999;281:841-844.
FULL TEXT  

Drug Therapy Before Coronary Artery Surgery: Nitrates Are Independent Predictors of Mortality and {beta}-Adrenergic Blockers Predict Survival
Weightman et al.
Anesth. Analg. 1999;88:286-286.
ABSTRACT | FULL TEXT  

Myocardial Infarction during Nifedipine Therapy for Preterm Labor
Oei et al.
NEJM 1999;340:154-154.
FULL TEXT  

Safety of Nifedipine in Angina Pectoris : A Meta-Analysis
Stason et al.
Hypertension 1999;33:24-31.
ABSTRACT | FULL TEXT  

Quality Improvement in the Diagnosis and Treatment of Heart Failure by Participating Indiana and Kentucky Hospitals
Caldwell et al.
Eval Health Prof 1998;21:461-471.
ABSTRACT  

Prevalence, Clinical Correlates, and Treatment of Hypertension in Elderly Nursing Home Residents
Gambassi et al.
Arch Intern Med 1998;158:2377-2385.
ABSTRACT | FULL TEXT  

Rationale and design of the International Verapamil SR/Trandolapril Study (INVEST): an Internet-based randomized trial in coronary artery disease patients with hypertension
Pepine et al.
J Am Coll Cardiol 1998;32:1228-1237.
ABSTRACT | FULL TEXT  

Calcium Antagonists and Mortality Risk in Men and Women With Hypertension in the Framingham Heart Study
Abascal et al.
Arch Intern Med 1998;158:1882-1886.
ABSTRACT | FULL TEXT  

National Patterns and Predictors of {beta}-Blocker Use in Patients With Coronary Artery Disease
Wang and Stafford
Arch Intern Med 1998;158:1901-1906.
ABSTRACT | FULL TEXT  

Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials
Dries et al.
J Am Coll Cardiol 1998;32:695-703.
ABSTRACT | FULL TEXT  

Calcium Channel Blockade and Cardiovascular Prognosis in the European Trial on Isolated Systolic Hypertension
Staessen et al.
Hypertension 1998;32:410-416.
ABSTRACT | FULL TEXT  

Fixed Low-Dose Drug Combination for the Treatment of Hypertension
Chrysant
Arch Fam Med 1998;7:370-376.
ABSTRACT | FULL TEXT  

Why Are Physicians Not Prescribing Diuretics More Frequently in the Management of Hypertension?
Moser
JAMA 1998;279:1813-1816.
ABSTRACT | FULL TEXT  

Short-Term Hemodynamic Effects of Mibefradil in Dogs With Chronic Heart Failure: Comparison With Diltiazem
Shimoyama et al.
J. Pharmacol. Exp. Ther. 1998;285:746-752.
ABSTRACT | FULL TEXT  

What Have We Learned From the Calcium Channel Blocker Controversy?
Califf and Kramer
Circulation 1998;97:1529-1531.
FULL TEXT  

Prospective Study of Calcium Channel Blocker Use, Cardiovascular Disease, and Total Mortality Among Hypertensive Women : The Nurses' Health Study
Michels et al.
Circulation 1998;97:1540-1548.
ABSTRACT | FULL TEXT  

Sodium Reduction and Weight Loss in the Treatment of Hypertension in Older Persons: A Randomized Controlled Trial of Nonpharmacologic Interventions in the Elderly (TONE)
Whelton et al.
JAMA 1998;279:839-846.
ABSTRACT | FULL TEXT  

The Effect of Nisoldipine as Compared with Enalapril on Cardiovascular Outcomes in Patients with Non-Insulin-Dependent Diabetes and Hypertension
Estacio et al.
NEJM 1998;338:645-652.
ABSTRACT | FULL TEXT  

Calcium-Channel Blockers for Hypertension -- Uncertainty Continues
Cutler
NEJM 1998;338:679-681.
FULL TEXT  

Conflict of Interest in the Debate over Calcium-Channel Antagonists
Stelfox et al.
NEJM 1998;338:101-106.
ABSTRACT | FULL TEXT  

Trends in Antihypertensive Drug Use in the United States: Do the JNC V Recommendations Affect Prescribing?
Siegel and Lopez
JAMA 1997;278:1745-1748.
ABSTRACT  

The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
Arch Intern Med 1997;157:2413-2446.
ABSTRACT  

A 42-Year-Old Man With Hypertension
Oparil
JAMA 1997;278:1015-1021.
ABSTRACT  

Successful Management of Refractory Hypertension With Dual Calcium Channel Blocker Therapy: Case Presentation
Geurian and Lipschitz
Arch Fam Med 1997;6:503-505.
ABSTRACT  

Safety of Nifedipine in Patients With Hypertension : A Meta-Analysis
Stason et al.
Hypertension 1997;30:7-14.
ABSTRACT | FULL TEXT  

Safety of Nifedipine in Patients With Hypertension : A Meta-Analysis
Stason et al.
Hypertension 1997;30 :7-14.
ABSTRACT | FULL TEXT  

Duration of Estrogen Replacement Therapy in Relation to the Risk of Incident Myocardial Infarction in Postmenopausal Women
Heckbert et al.
Arch Intern Med 1997;157:1330-1336.
ABSTRACT  

General Internal Medicine
Larson and Sheffield
JAMA 1997;277:1860-1861.
 

Short-Acting Nifedipine and Diltiazem Do Not Reduce the Incidence of Cardiac Events in Patients With Healed Myocardial Infarction
Ishikawa et al.
Circulation 1997;95:2368-2373.
ABSTRACT | FULL TEXT  

The Messenger under Attack -- Intimidation of Researchers by Special-Interest Groups
Deyo et al.
NEJM 1997;336:1176-1180.
FULL TEXT  

Health Outcomes Associated With Antihypertensive Therapies Used as First-Line Agents: A Systematic Review and Meta-analysis
Psaty et al.
JAMA 1997;277:739-745.
ABSTRACT  

Efficacy and Safety of Nifedipine Coat-Core versus Amlodipine in Patients With Mild to Moderate Essential Hypertension: Comparison of 24-Hour Mean Ambulatory Diastolic Blood Pressure
Byyny et al.
J CARDIOVASC PHARMACOL THER 1997;2:77-83.
ABSTRACT  

Evidence for the risk of calcium channel blockers in hypertension was selective
Hanna et al.
BMJ 1996;313:1259c-1260.
FULL TEXT  

Hypertension Treatment: Its Past and (Perhaps) Its Future
Dustan
Arch Intern Med 1996;156:1913-1914.
ABSTRACT  

Final Outcome Results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS) A Randomized Controlled Trial
Borhani et al.
JAMA 1996;276:785-791.
ABSTRACT  

Calcium Channel Blockers: Lessons Learned From MIDAS and Other Clinical Trials
Chobanian
JAMA 1996;276:829-830.
ABSTRACT  

Comparison of Nifedipine Alone and With Diltiazem or Verapamil in Hypertension
Saseen et al.
Hypertension 1996;28:109-114.
ABSTRACT | FULL TEXT  

General Internal Medicine
Petersen and Daley
JAMA 1996;275:1811-1812.
ABSTRACT